QGEN Proyeksi bathi mangsa ngarep Qiagen

Simbol lan logo merek Qiagen NV (QGEN)

The price action of Qiagen N.V. (QGEN) securities reflects profit dynamics, which currently stand at 0.54. The business relies on the production of molecular analysis tools and scientific reagents, minimizing risks through a broad product portfolio. Patent protection and the high switching costs for clinics moving to alternative test systems block competitor access. Leadership in tuberculosis diagnostics and the launch of digital PCR platforms further strengthen its market position.

QGEN: Bathi resik sing dikarepake Qiagen N.V. 04.07.2022 - 18.11.2026

Qiagen Corp - rincian analitis lan metrik utama (QGEN)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:Qiagen NV
Produk merek Qiagen Group

Qiagen N.V. (QGEN) leverages its gold-standard status in molecular diagnostics to effectively pass inflationary costs onto consumers, maintaining high business margins. An analysis of the forward profitability trend demonstrates the company's ability to generate future cash flow, where a stable or ascending line confirms the fundamental resilience of the asset's market value and the absence of operational stagnation.

Analisis pesaing

Bathi sing dikarepake Tempus AI|Prakiraan bathi resik IONS (Ionis)|Bathi sing dikarepake Repligen Corp. (RGEN)|Prakiraan bathi perusahaan Avidity Biosciences|Bathi sing dikarepake CRISPR Therapeutics Corp CRSP|WGS: Prakiraan bathi resik|ultragenyx.com - Proyeksi bathi mangsa ngarep|Beam Therapeutics - Bathi resik mangsa ngarep|SRPT: Proyeksi bathi mangsa ngarep|TWST (Twist Bio) - Bathi sing dikarepake|TXG (10xgenomics.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Intellia Therapeutics, Inc.|Proyeksi bathi mangsa ngarep STOK|Prakiraan bathi perusahaan BioLife Solutions Inc|Bathi sing dikarepake Wave Pharma WVE|Proyeksi bathi mangsa ngarep Maze Therapeutics Corp MAZE|SION - Bathi sing dikarepake|Prime Medicine, Inc. (PRME) - Bathi mangsa ngarep|TSHA (Taysha Gene Therapies, Inc.) - Bathi mangsa ngarep|QURE - Prakiraan bathi perusahaan|MGTX (MeiraGTx Holdings plc) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep REGENXBIO Inc. (RGNX)|Bathi sing dikarepake Solid Biosciences (SLDB)|ocugen.com (OCGN) - Proyeksi bathi resik|Proyeksi bathi mangsa ngarep PACB (PacBio Corp)|Penghasilan resik sing dikarepake BNTC|DSGN: Bathi mangsa ngarep|RCKT - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake 4D Molecular Corp FDMT|Bathi mangsa ngarep Lexeo|Bathi sing dikarepake Korro Bio Inc.|Prakiraan bathi resik EDIT (Editas Medicine)|Bathi sing dikarepake Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CDXS (Codexis, Inc.)|Prakiraan bathi perusahaan sangamo.com (SGMO)|nautilus.bio - Proyeksi bathi mangsa ngarep|Metagenomi (MGX) - Bathi mangsa ngarep|DTIL: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Exicure (XCUR)|Bathi sing dikarepake Celsion Corporation (IMNN)|PHIO - Bathi resik sing dikarepake|Mustang Bio Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Proyeksi bathi mangsa ngarep|APDN (Applied DNA Sciences) - Prakiraan bathi resik|BLUE (bluebirdbio.com) - Bathi mangsa ngarep|Prakiraan bathi resik IPA|OMGA (omegatherapeutics.com) - Proyeksi bathi mangsa ngarep|Singular Genomics Systems Inc (OMIC) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep RGLS|Prakiraan bathi perusahaan Syros Pharmaceuticals, Inc.|Bathi sing dikarepake Telesis Bio Inc. TBIO|Bathi resik mangsa ngarep TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Proyeksi bathi mangsa ngarep